User contributions
- 11:15, 5 February 2018 (diff | hist) . . (+6) . . Pharmacovigilance Conferences
- 11:14, 5 February 2018 (diff | hist) . . (+29) . . Pharmacovigilance Conferences
- 11:12, 5 February 2018 (diff | hist) . . (+2) . . Pharmacovigilance Conferences
- 11:10, 5 February 2018 (diff | hist) . . (-59) . . Pharmacovigilance Conferences
- 11:00, 5 February 2018 (diff | hist) . . (-3,958) . . Pharmacovigilance Conferences (Tag: VisualEditor)
- 03:42, 30 June 2017 (diff | hist) . . (+1) . . Pharmacovigilance Conferences
- 03:40, 30 June 2017 (diff | hist) . . (+197) . . Pharmacovigilance Conferences
- 10:22, 29 June 2017 (diff | hist) . . (+65) . . Pharmacovigilance
- 04:19, 28 June 2017 (diff | hist) . . (+98) . . Pharmacovigilance Conferences
- 05:21, 21 June 2017 (diff | hist) . . (+296) . . Adverse drug reaction (→Causality Assessment could be performed using the following WHO definitions:http://www.epnetwork.org/Resources/Pharmacovigilance/WHO-draft-guidelines-pharmacovigilance.pdf)
- 04:59, 21 June 2017 (diff | hist) . . (+249) . . Pharmacovigilance
- 04:54, 21 June 2017 (diff | hist) . . (+83) . . Pharmacovigilance
- 04:44, 21 June 2017 (diff | hist) . . (+117) . . Pharmacovigilance
- 03:55, 21 June 2017 (diff | hist) . . (+142) . . Nm userpage of Safnaz UK (Creating userpage) (current)
